Search Within

Karthik Nath

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (9)
  3. Review (3)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. GME, Medicine (31)
  4. Graduate Medical Education (31)
  5. Hematologic Malignancies, Division of (31)
  6. Bone Marrow Transplant (27)

More Groups

People
  1. Gunjan Shah (22)
  2. Sergio Giralt (22)
  3. Michael Scordo (20)
  4. Sean Devlin (16)
  5. Sham Mailankody (15)
  6. Miguel-Angel Perales (14)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (14)
  4. 2022 (9)
Publications
  1. Blood (9)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Bone Marrow Transplantation (3)
  4. Transplantation and Cellular Therapy (3)
  5. Blood Cancer Journal (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Elsevier Inc. (9)
  3. Nature Publishing Group (8)
  4. Ferrata Storti Foundation (1)
  5. Informa Healthcare (1)
  6. John Wiley & Sons, Inc. (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comparative analysis of infectious complications in patients with multiple myeloma treated with BCMA-targeted bispecific antibodies and CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Shekarkhand, T.; Costa, B. A.; Nemirovsky, D.; Derkach, A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D.; Landau, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Nath, K.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Flynn, J.; Nath, K.; Nishimura, N.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
    Journal Article

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • CAR T-cell therapy for multiple myeloma: A clinical practice-oriented review
    Review

    Sadek, N. L.; Costa, B. A.; Nath, K.; Mailankody, S.
    Clinical Pharmacology & Therapeutics (2023)

    Fulltext@MSK | Save
  • The role of chimeric antigen receptor T-cell therapy in the era of bispecific antibodies
    Review

    Nath, K.; Mailankody, S.; Usmani, S. Z.
    Hematology/Oncology Clinics of North America (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • GPRC5D as a novel immunotherapeutic target in multiple myeloma
    Editorial

    Nath, K.; Costa, B. A.; Mailankody, S.
    Nature Reviews Clinical Oncology (2023)

    Fulltext@MSK | Save